AKT1 and cancer: Upregulation of MASTL kinase in different kinds of cancer has been functionally associated with oncogenic transformation through the hyperactivation of oncogenic kinase AKT‐ or Wnt/β‐catenin signaling and resistance to anticancer therapy.